- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Drug Eluting Peripheral Stents market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Drug Eluting Peripheral Stents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Drug Eluting Peripheral Stents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Drug Eluting Peripheral Stents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Drug Eluting Peripheral Stents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Drug Eluting Peripheral Stents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Eluting Peripheral Stents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Eluting Peripheral Stents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific Corporation, W. L. Gore & Associates, Abbott Laboratories, iVascular SLU. and Meril Life Sciences Pvt. Ltd. and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Drug Eluting Peripheral Stents market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Carotid Artery
Iliac Artery
Infrapop Artery
Renal Artery
Carotid Artery
Market segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers/Outpatients
Major players covered
Boston Scientific Corporation
W. L. Gore & Associates
Abbott Laboratories
iVascular SLU.
Meril Life Sciences Pvt. Ltd.
Stentys SA, Cook Medical Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Peripheral Stents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drug Eluting Peripheral Stents, with price, sales, revenue and global market share of Drug Eluting Peripheral Stents from 2018 to 2023.
Chapter 3, the Drug Eluting Peripheral Stents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Peripheral Stents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Drug Eluting Peripheral Stents market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Eluting Peripheral Stents.
Chapter 14 and 15, to describe Drug Eluting Peripheral Stents sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Drug Eluting Peripheral Stents
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Drug Eluting Peripheral Stents Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Carotid Artery
1.3.3 Iliac Artery
1.3.4 Infrapop Artery
1.3.5 Renal Artery
1.3.6 Carotid Artery
1.4 Market Analysis by Application
1.4.1 Overview: Global Drug Eluting Peripheral Stents Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Ambulatory Surgical Centers/Outpatients
1.5 Global Drug Eluting Peripheral Stents Market Size & Forecast
1.5.1 Global Drug Eluting Peripheral Stents Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Drug Eluting Peripheral Stents Sales Quantity (2018-2029)
1.5.3 Global Drug Eluting Peripheral Stents Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Boston Scientific Corporation
2.1.1 Boston Scientific Corporation Details
2.1.2 Boston Scientific Corporation Major Business
2.1.3 Boston Scientific Corporation Drug Eluting Peripheral Stents Product and Services
2.1.4 Boston Scientific Corporation Drug Eluting Peripheral Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boston Scientific Corporation Recent Developments/Updates
2.2 W. L. Gore & Associates
2.2.1 W. L. Gore & Associates Details
2.2.2 W. L. Gore & Associates Major Business
2.2.3 W. L. Gore & Associates Drug Eluting Peripheral Stents Product and Services
2.2.4 W. L. Gore & Associates Drug Eluting Peripheral Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 W. L. Gore & Associates Recent Developments/Updates
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Drug Eluting Peripheral Stents Product and Services
2.3.4 Abbott Laboratories Drug Eluting Peripheral Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Laboratories Recent Developments/Updates
2.4 iVascular SLU.
2.4.1 iVascular SLU. Details
2.4.2 iVascular SLU. Major Business
2.4.3 iVascular SLU. Drug Eluting Peripheral Stents Product and Services
2.4.4 iVascular SLU. Drug Eluting Peripheral Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 iVascular SLU. Recent Developments/Updates
2.5 Meril Life Sciences Pvt. Ltd.
2.5.1 Meril Life Sciences Pvt. Ltd. Details
2.5.2 Meril Life Sciences Pvt. Ltd. Major Business
2.5.3 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product and Services
2.5.4 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Meril Life Sciences Pvt. Ltd. Recent Developments/Updates
2.6 Stentys SA, Cook Medical Inc.
2.6.1 Stentys SA, Cook Medical Inc. Details
2.6.2 Stentys SA, Cook Medical Inc. Major Business
2.6.3 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product and Services
2.6.4 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Stentys SA, Cook Medical Inc. Recent Developments/Updates
3 Competitive Environment: Drug Eluting Peripheral Stents by Manufacturer
3.1 Global Drug Eluting Peripheral Stents Sales Quantity by Manufacturer (2018-2023)
3.2 Global Drug Eluting Peripheral Stents Revenue by Manufacturer (2018-2023)
3.3 Global Drug Eluting Peripheral Stents Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Drug Eluting Peripheral Stents by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Drug Eluting Peripheral Stents Manufacturer Market Share in 2022
3.4.2 Top 6 Drug Eluting Peripheral Stents Manufacturer Market Share in 2022
3.5 Drug Eluting Peripheral Stents Market: Overall Company Footprint Analysis
3.5.1 Drug Eluting Peripheral Stents Market: Region Footprint
3.5.2 Drug Eluting Peripheral Stents Market: Company Product Type Footprint
3.5.3 Drug Eluting Peripheral Stents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Drug Eluting Peripheral Stents Market Size by Region
4.1.1 Global Drug Eluting Peripheral Stents Sales Quantity by Region (2018-2029)
4.1.2 Global Drug Eluting Peripheral Stents Consumption Value by Region (2018-2029)
4.1.3 Global Drug Eluting Peripheral Stents Average Price by Region (2018-2029)
4.2 North America Drug Eluting Peripheral Stents Consumption Value (2018-2029)
4.3 Europe Drug Eluting Peripheral Stents Consumption Value (2018-2029)
4.4 Asia-Pacific Drug Eluting Peripheral Stents Consumption Value (2018-2029)
4.5 South America Drug Eluting Peripheral Stents Consumption Value (2018-2029)
4.6 Middle East and Africa Drug Eluting Peripheral Stents Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2029)
5.2 Global Drug Eluting Peripheral Stents Consumption Value by Type (2018-2029)
5.3 Global Drug Eluting Peripheral Stents Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2029)
6.2 Global Drug Eluting Peripheral Stents Consumption Value by Application (2018-2029)
6.3 Global Drug Eluting Peripheral Stents Average Price by Application (2018-2029)
7 North America
7.1 North America Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2029)
7.2 North America Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2029)
7.3 North America Drug Eluting Peripheral Stents Market Size by Country
7.3.1 North America Drug Eluting Peripheral Stents Sales Quantity by Country (2018-2029)
7.3.2 North America Drug Eluting Peripheral Stents Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2029)
8.2 Europe Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2029)
8.3 Europe Drug Eluting Peripheral Stents Market Size by Country
8.3.1 Europe Drug Eluting Peripheral Stents Sales Quantity by Country (2018-2029)
8.3.2 Europe Drug Eluting Peripheral Stents Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Drug Eluting Peripheral Stents Market Size by Region
9.3.1 Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Drug Eluting Peripheral Stents Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2029)
10.2 South America Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2029)
10.3 South America Drug Eluting Peripheral Stents Market Size by Country
10.3.1 South America Drug Eluting Peripheral Stents Sales Quantity by Country (2018-2029)
10.3.2 South America Drug Eluting Peripheral Stents Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Drug Eluting Peripheral Stents Market Size by Country
11.3.1 Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Drug Eluting Peripheral Stents Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Drug Eluting Peripheral Stents Market Drivers
12.2 Drug Eluting Peripheral Stents Market Restraints
12.3 Drug Eluting Peripheral Stents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Drug Eluting Peripheral Stents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drug Eluting Peripheral Stents
13.3 Drug Eluting Peripheral Stents Production Process
13.4 Drug Eluting Peripheral Stents Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Drug Eluting Peripheral Stents Typical Distributors
14.3 Drug Eluting Peripheral Stents Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Drug Eluting Peripheral Stents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Drug Eluting Peripheral Stents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 4. Boston Scientific Corporation Major Business
Table 5. Boston Scientific Corporation Drug Eluting Peripheral Stents Product and Services
Table 6. Boston Scientific Corporation Drug Eluting Peripheral Stents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Boston Scientific Corporation Recent Developments/Updates
Table 8. W. L. Gore & Associates Basic Information, Manufacturing Base and Competitors
Table 9. W. L. Gore & Associates Major Business
Table 10. W. L. Gore & Associates Drug Eluting Peripheral Stents Product and Services
Table 11. W. L. Gore & Associates Drug Eluting Peripheral Stents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. W. L. Gore & Associates Recent Developments/Updates
Table 13. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Laboratories Major Business
Table 15. Abbott Laboratories Drug Eluting Peripheral Stents Product and Services
Table 16. Abbott Laboratories Drug Eluting Peripheral Stents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abbott Laboratories Recent Developments/Updates
Table 18. iVascular SLU. Basic Information, Manufacturing Base and Competitors
Table 19. iVascular SLU. Major Business
Table 20. iVascular SLU. Drug Eluting Peripheral Stents Product and Services
Table 21. iVascular SLU. Drug Eluting Peripheral Stents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. iVascular SLU. Recent Developments/Updates
Table 23. Meril Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Meril Life Sciences Pvt. Ltd. Major Business
Table 25. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product and Services
Table 26. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Meril Life Sciences Pvt. Ltd. Recent Developments/Updates
Table 28. Stentys SA, Cook Medical Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Stentys SA, Cook Medical Inc. Major Business
Table 30. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product and Services
Table 31. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Stentys SA, Cook Medical Inc. Recent Developments/Updates
Table 33. Global Drug Eluting Peripheral Stents Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Drug Eluting Peripheral Stents Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Drug Eluting Peripheral Stents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in Drug Eluting Peripheral Stents, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Drug Eluting Peripheral Stents Production Site of Key Manufacturer
Table 38. Drug Eluting Peripheral Stents Market: Company Product Type Footprint
Table 39. Drug Eluting Peripheral Stents Market: Company Product Application Footprint
Table 40. Drug Eluting Peripheral Stents New Market Entrants and Barriers to Market Entry
Table 41. Drug Eluting Peripheral Stents Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Drug Eluting Peripheral Stents Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Drug Eluting Peripheral Stents Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Drug Eluting Peripheral Stents Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Drug Eluting Peripheral Stents Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Drug Eluting Peripheral Stents Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global Drug Eluting Peripheral Stents Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Drug Eluting Peripheral Stents Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Drug Eluting Peripheral Stents Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Drug Eluting Peripheral Stents Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Drug Eluting Peripheral Stents Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global Drug Eluting Peripheral Stents Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Drug Eluting Peripheral Stents Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Drug Eluting Peripheral Stents Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Drug Eluting Peripheral Stents Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Drug Eluting Peripheral Stents Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global Drug Eluting Peripheral Stents Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Drug Eluting Peripheral Stents Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Drug Eluting Peripheral Stents Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Drug Eluting Peripheral Stents Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Drug Eluting Peripheral Stents Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Drug Eluting Peripheral Stents Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Drug Eluting Peripheral Stents Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Drug Eluting Peripheral Stents Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Drug Eluting Peripheral Stents Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Drug Eluting Peripheral Stents Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Drug Eluting Peripheral Stents Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Drug Eluting Peripheral Stents Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Drug Eluting Peripheral Stents Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Drug Eluting Peripheral Stents Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Drug Eluting Peripheral Stents Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Drug Eluting Peripheral Stents Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Drug Eluting Peripheral Stents Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Drug Eluting Peripheral Stents Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Drug Eluting Peripheral Stents Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Drug Eluting Peripheral Stents Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Drug Eluting Peripheral Stents Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Drug Eluting Peripheral Stents Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Drug Eluting Peripheral Stents Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Drug Eluting Peripheral Stents Raw Material
Table 101. Key Manufacturers of Drug Eluting Peripheral Stents Raw Materials
Table 102. Drug Eluting Peripheral Stents Typical Distributors
Table 103. Drug Eluting Peripheral Stents Typical Customers
List of Figures
Figure 1. Drug Eluting Peripheral Stents Picture
Figure 2. Global Drug Eluting Peripheral Stents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Drug Eluting Peripheral Stents Consumption Value Market Share by Type in 2022
Figure 4. Carotid Artery Examples
Figure 5. Iliac Artery Examples
Figure 6. Infrapop Artery Examples
Figure 7. Renal Artery Examples
Figure 8. Carotid Artery Examples
Figure 9. Global Drug Eluting Peripheral Stents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Drug Eluting Peripheral Stents Consumption Value Market Share by Application in 2022
Figure 11. Hospitals Examples
Figure 12. Specialty Clinics Examples
Figure 13. Ambulatory Surgical Centers/Outpatients Examples
Figure 14. Global Drug Eluting Peripheral Stents Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Drug Eluting Peripheral Stents Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Drug Eluting Peripheral Stents Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Drug Eluting Peripheral Stents Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Drug Eluting Peripheral Stents Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Drug Eluting Peripheral Stents Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Drug Eluting Peripheral Stents by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Drug Eluting Peripheral Stents Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Drug Eluting Peripheral Stents Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Drug Eluting Peripheral Stents Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Drug Eluting Peripheral Stents Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Drug Eluting Peripheral Stents Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Drug Eluting Peripheral Stents Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Drug Eluting Peripheral Stents Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Drug Eluting Peripheral Stents Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Drug Eluting Peripheral Stents Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Drug Eluting Peripheral Stents Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Drug Eluting Peripheral Stents Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Drug Eluting Peripheral Stents Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Drug Eluting Peripheral Stents Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Drug Eluting Peripheral Stents Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Drug Eluting Peripheral Stents Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Drug Eluting Peripheral Stents Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Drug Eluting Peripheral Stents Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Drug Eluting Peripheral Stents Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Drug Eluting Peripheral Stents Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Drug Eluting Peripheral Stents Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Drug Eluting Peripheral Stents Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Drug Eluting Peripheral Stents Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Drug Eluting Peripheral Stents Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Drug Eluting Peripheral Stents Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Drug Eluting Peripheral Stents Consumption Value Market Share by Region (2018-2029)
Figure 56. China Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Drug Eluting Peripheral Stents Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Drug Eluting Peripheral Stents Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Drug Eluting Peripheral Stents Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Drug Eluting Peripheral Stents Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Drug Eluting Peripheral Stents Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Drug Eluting Peripheral Stents Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Drug Eluting Peripheral Stents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Drug Eluting Peripheral Stents Market Drivers
Figure 77. Drug Eluting Peripheral Stents Market Restraints
Figure 78. Drug Eluting Peripheral Stents Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Drug Eluting Peripheral Stents in 2022
Figure 81. Manufacturing Process Analysis of Drug Eluting Peripheral Stents
Figure 82. Drug Eluting Peripheral Stents Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
